Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial
Northwest Biotherapeutics (OTC.BB: NWBO) announced that it has accelerated the addition of clinical trial sites, exceeding its projections for the doubling of such sites across the U.S. this calendar...
View ArticleMDxHealth’s Methylation Based Companion Diagnostics Enables Better...
MDxHealth SA (BSE:MDXH), a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that its MGMT test (Predict MDx for Brain) has demonstrated success in...
View ArticleJust Add Water And … Treat Brain Cancer
Researchers at the Johns Hopkins University School of Medicine have developed a technique that delivers gene therapy into human brain cancer cells using nanoparticles that can be freeze-dried and...
View ArticleCancer Research UK Launches Trial to Treat Brain Cancer which has Returned
Cancer Research UK’s Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer. The Phase I clinical trial will take place at The Beatson...
View ArticleMechanism Discovered In Neuron Responsible For Neuron Death
Researchers from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have discovered a mechanism by which glioblastoma multiforme (GBM), the most common...
View Article
